mepolizumab in the United States

8 medicine records from 3 holders carry this name in the official sources. Collected on November 16, 2026.

Medicines

Holders and status of these records
Name Holder Code
mepolizumab LIQUID GlaxoSmithKline LLC Product NDC 49401-012Package NDC 49401-012-91
mepolizumab LIQUID GlaxoSmithKline LLC Product NDC 58437-004Package NDC 58437-004-01
mepolizumab LIQUID GlaxoSmithKline LLC Product NDC 58437-009Package NDC 58437-009-01
mepolizumab LIQUID SAMSUNG BIOLOGICS Co., Ltd. Product NDC 71124-0063Package NDC 71124-0063-0
Mepolizumab Drug Substance LIQUID Lonza Biologics, Inc. Product NDC 67643-0035Package NDC 67643-0035-1
Nucala INJECTION, POWDER, FOR SOLUTION GlaxoSmithKline LLC Product NDC 0173-0881Package NDC 0173-0881-01
Nucala INJECTION, SOLUTION GlaxoSmithKline LLC Product NDC 0173-0892Package NDC 0173-0892-01
Nucala INJECTION, SOLUTION GlaxoSmithKline LLC Product NDC 0173-0904Package NDC 0173-0904-42

Need this list in your own system?

Every record on this page is available through the API, with its source, licence and retrieval date.